Back to search
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hydroxymethylglutaryl-CoA Reductase Inhibitors trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hydroxymethylglutaryl-CoA Reductase Inhibitors trials you may qualify forThe goal of this double-blind randomized controlled trial is to determine how treatment with high intensity statin, low-dose colchicine, and their combination m…
This study aims to investigate how different types and intensities of exercise affect muscle recovery in individuals taking statin medications compared to healt…
Interventional study to compare standard of care vs standard of care plus the use of a medication therapy management smartphone app (mediteo m+, Mediteo GmbH, H…
The goal of this clinical trial is to learn whether statin therapy and vitamin D supplementation can modify disease activity in patients with active thyroid eye…
The rationale of our study is to observe the incidence of MACE in RA patients treated with tofacitinib along with statins with one or more cardiovascular diseas…
Intracranial atherosclerotic disease is the most common cause of ischemic stroke that is directly attributed to the progression or rupture of intracranial high-…
Statins are among the most widely prescribed drugs worldwide, and their benefits in cardiovascular risk reduction are well established. Beyond lipid lowering, s…
Statins have been demonstrated to significantly reduce the risk of cardiovascular disease, but adherence to these medications is suboptimal. Improving adherence…
The investigators hypothesize that pre-operative statin use is neuroprotective at maximal doses. The goals are to determine the safety, feasibility, and efficac…